Speaker illustration

Doctor Casper Niels Bang

Novo Nordisk, Soeborg (Denmark)

Member of:

European Society of Cardiology

- I am a trained electrophysiologist, and have implanted >400 electrophysiological devices including single and double chamber pacemaker and single and double chamber ICDs. - I have been research director at North Zealand Hospital in Department of Cardiology. In my current position, I am managing my own research group, which consists of two research year students and six PhD students. - I am collaborating with several international leading researches including Professor Richard Devereux and Professor Peter Okin (Weill Cornell Medical College, New York, USA). - Since beginning of my research career my focus has been epidemiological research. However, the last couple of years I have initiated two large national clinical studies. One study, the DANNOAC study, was a cluster randomized study to test which blood-thinning drug was the safest in the treatment of atrial fibrillation.

Patient reported symptoms in emergency health care service in patients with complete atrioventricular block

Event: ESC Congress 2022

Topic: Pacemaker Therapy

Session: Evaluation and treatment of conduction disease in 2022

Thumbnail

Incident atrial fibrillation and heart failure in treated hypertensive patients with left ventricular hypertrophy

Event: ESC Congress 2022

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: Hypertension - Pathophysiology and mechanisms 2

Thumbnail

Left atrial systolic force in hypertensive patients with left ventricular hypertrophy predicts atrial fibrillation.

Event: ESC Congress 2022

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: Hypertension - Pathophysiology and mechanisms 2

Thumbnail

NT-proBNP adds incremental predictive information on incident atrial fibrillation in patients with asymptomatic aortic stenosis

Event: ESC Congress 2019

Topic: Diagnostic Methods

Session: Epidemiology of atrial fibrillation

Thumbnail

Reverse Takotsubo cardiomyopathy and cardiogenic shock after amphetamine intake in schizophrenic patient with loop recorder.

Event: ESC Congress 2019

Topic: Cardiogenic Shock

Session: Acute Cardiac Care

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb